A combination of genetic and lab testing could identify 1 million Americans who are at risk of early death from heart disease because they carry a gene that causes high cholesterol.
The Columbia Hypertension Center has been certified by the American Heart Association, recognition that Columbia is a leader in the care of patients with high blood pressure.
Researchers are collaborating with the NBA to create a new standard in the detection and reduction of cardiac risk among professional basketball athletes.
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a new study from Columbia researchers.
A new study has revealed that cholesterol-lowering statins may help reverse the mechanisms that increase the risk of heart disease in people with sleep apnea.
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
The NIH has granted $8.56 million for a first of its kind clinical trial examining cardiovascular disease in patients with rheumatoid arthritis. One of the principal investigators is Columbia's Joan Bathon.
Columbia researcher Jon Giles has published research showing a link between atherosclerosis and depressive symptoms, stress, anxiety, anger, and lack of social support in patients with rheumatoid arthritis.
Columbia research shows that expanding treatment of high blood pressure with cost-effective medication could prevent 1 million heart attacks and strokes in China.